Logo-npj
Submitted: 12 May 2018
Accepted: 03 Jul 2018
ePublished: 28 Jul 2018
EndNote EndNote

(Enw Format - Win & Mac)

BibTeX BibTeX

(Bib Format - Win & Mac)

Bookends Bookends

(Ris Format - Mac only)

EasyBib EasyBib

(Ris Format - Win & Mac)

Medlars Medlars

(Txt Format - Win & Mac)

Mendeley Web Mendeley Web
Mendeley Mendeley

(Ris Format - Win & Mac)

Papers Papers

(Ris Format - Win & Mac)

ProCite ProCite

(Ris Format - Win & Mac)

Reference Manager Reference Manager

(Ris Format - Win only)

Refworks Refworks

(Refworks Format - Win & Mac)

Zotero Zotero

(Ris Format - Firefox Plugin)

J Nephropharmacol. 2018;7(2): 149-155.
doi: 10.15171/npj.2018.30
  Abstract View: 8477
  PDF Download: 4386

Original

The effect of coenzyme Q10 on cognitive status in chronic hemodialysis patients; a double-blind, randomized, clinical trial

Mohammad Reza Tamadon 1*, Majid Mirmohammadkhani 2, Shahb Rafaati 3

1 Department of Nephrology, Semnan University of Medical Sciences, Semnan, Iran
2 Social Determinants of Health Research Center, Semnan University of Medical Sciences, Semnan, Iran
3 Resident of Internal Medicine, Department of Internal Medicine, Semnan University of Medical Sciences, Semnan, Iran
*Corresponding Author: *Corresponding author: Prof. Mohammad Reza Tamadon, Email: , Email: mrt_tamadon@yahoo.com

Abstract

Introduction: Renal failure is a stressful process that has several complications, including neurological disorders such as cognitive disorder, which can lead to the incidence of psychological disorders.

Objectives: Given the reduced coenzyme Q10 levels in patients with chronic renal failure and the known role of this coenzyme in cognitive disorders, the present study was conducted to assess the effect of CoQ10 supplementation in the treatment of cognitive disorder in hemodialysis patients in Semnan, Iran.

Patients and Methods: The present double-blind, randomized, clinical trial was conducted on patients with chronic renal failure undergoing hemodialysis at Kosar Hospital of Semnan. The participants underwent a cognitive assessment using the Mini-Mental State Examination (MMSE). They were then randomly divided into two groups; group one received CoQ10 supplement and group two received placebo for 90 days, after which period they underwent another cognitive assessment using the MMSE. The Kolmogorov-Smirnov test and Levene’s test were used to verify the normal distribution of the data. Data were analyzed using the t test and Mann–Whitney U test at a significance level of P<0.05.

Results: There were no statistically significant differences between the two groups in terms of their personal details. The mean (± standard deviation) of the MMSE1 score was 21.29±6.5 in the control group and 21.09±5.4 in the case group. The mean (± standard deviation) of the MMSE2 score was 20.62±6.5 in the control group and 23.29±5.8 in the case group. A significant difference between the two groups in terms of their pre- and post-intervention MMSE scores was observed, suggesting the positive effect of the medication (P<0.001).

Conclusion: The daily intake of CoQ10 100-mg led to a significant change in the cognitive status of chronic hemodialysis patients compared to the group that received only the placebo. Conducting a similar study but with the addition of a healthy control group is recommended in order to establish a base measure for the healthy population and to thus enable the better interpretation of the effect of this supplement. 


Implication for health policy/practice/research/medical education:

Renal failure is a stressful process that has several complications, including neurological disorders such as cognitive disorder, which can lead to the incidence of psychological disorders. Given the reduced coenzyme Q10 (CoQ10) levels in patients with chronic renal failure and the known role of this coenzyme in cognitive disorders, the present study indicated that daily intake of CoQ10 100-mg led to a significant change in the cognitive status of chronic hemodialysis patients compared to the group that received only the placebo.

Please cite this paper as: Tamadon MR, Mirmohammadkhani M, Rafaati S. The effect of coenzyme Q10 on cognitive status in chronic hemodialysis patients; a double-blind, randomized, clinical trial. J Nephropharmacol. 2018;7(2):149-155. 

First Name
Last Name
Email Address
Comments
Security code


Abstract View: 8478

Your browser does not support the canvas element.


PDF Download: 4386

Your browser does not support the canvas element.